GNWRX
Price
$32.42
Change
-$0.01 (-0.03%)
Updated
Aug 7 closing price
Net Assets
1.76B
VSTSX
Price
$298.03
Change
-$0.27 (-0.09%)
Updated
Aug 7 closing price
Net Assets
1.91T
Interact to see
Advertisement

GNWRX vs VSTSX

Header iconGNWRX vs VSTSX Comparison
Open Charts GNWRX vs VSTSXBanner chart's image
Nationwide R
Price$32.42
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets1.76B
Vanguard Total Stock Mkt Idx Instl Sel
Price$298.03
Change-$0.27 (-0.09%)
VolumeN/A
Net Assets1.91T
GNWRX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GNWRX vs. VSTSX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNWRX is a Buy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. GNWRX (1.76B). VSTSX pays higher dividends than GNWRX: VSTSX (1.20) vs GNWRX (0.00). GNWRX was incepted earlier than VSTSX: GNWRX (22 years) vs VSTSX (9 years). GNWRX (1.34) is less costly to investors than VSTSX (0.01). GNWRX is a more actively managed with annual turnover of: 83.61 vs. VSTSX (2.00). GNWRX has a lower initial minimum investment than VSTSX: GNWRX (0) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.80 vs. GNWRX (9.16). VSTSX return over 5 years is better than : 84.04 vs. GNWRX (32.14).
GNWRXVSTSXGNWRX / VSTSX
Total Expense Ratio1.300.0113,000%
Annual Report Gross Expense Ratio1.340.0113,400%
Fund Existence22 years9 years-
Gain YTD6.9947.46894%
Front LoadN/AN/A-
Min. Initial Investment05000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.76B1.91T0%
Annual Yield % from dividends0.001.20-
Returns for 1 year9.1621.8042%
Returns for 3 years28.2050.2756%
Returns for 5 years32.1484.0438%
Returns for 10 years45.72N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOLN3.660.18
+5.32%
Molecular Partners AG
LYRA6.890.11
+1.62%
Lyra Therapeutics Inc
AACT11.39-0.02
-0.18%
Ares Acquisition Corp
IEX158.53-1.19
-0.75%
IDEX Corp
HCM16.31-1.61
-9.01%
HUTCHMED (China) Limited